State Street’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $411K | Sell |
287,373
-937,045
| -77% | -$1.34M | ﹤0.01% | 3660 |
|
|
2025
Q1 | $1.96M | Buy |
1,224,418
+1,400
| +0.1% | +$2.24K | ﹤0.01% | 3252 |
|
|
2024
Q4 | $4.4M | Sell |
1,223,018
-1,583,895
| -56% | -$5.7M | ﹤0.01% | 3027 |
|
|
2024
Q3 | $16M | Sell |
2,806,913
-188,035
| -6% | -$1.07M | ﹤0.01% | 2341 |
|
|
2024
Q2 | $13.8M | Sell |
2,994,948
-4,158,332
| -58% | -$19.2M | ﹤0.01% | 2367 |
|
|
2024
Q1 | $58.4M | Buy |
7,153,280
+6,997,907
| +4,504% | +$57.2M | ﹤0.01% | 1642 |
|
|
2023
Q4 | $878K | Hold |
155,373
| – | – | ﹤0.01% | 3507 |
|
|
2023
Q3 | $289K | Hold |
155,373
| – | – | ﹤0.01% | 3831 |
|
|
2023
Q2 | $427K | Sell |
155,373
-618,848
| -80% | -$1.7M | ﹤0.01% | 3731 |
|
|
2023
Q1 | $2.43M | Sell |
774,221
-1,673,376
| -68% | -$5.25M | ﹤0.01% | 3278 |
|
|
2022
Q4 | $14.4M | Buy |
2,447,597
+485,785
| +25% | +$2.87M | ﹤0.01% | 2465 |
|
|
2022
Q3 | $17.2M | Buy |
1,961,812
+1,245,369
| +174% | +$10.9M | ﹤0.01% | 2332 |
|
|
2022
Q2 | $5.4M | Sell |
716,443
-1,511,316
| -68% | -$11.4M | ﹤0.01% | 3064 |
|
|
2022
Q1 | $54M | Buy |
2,227,759
+638,006
| +40% | +$15.5M | ﹤0.01% | 1709 |
|
|
2021
Q4 | $51.2M | Sell |
1,589,753
-68,877
| -4% | -$2.22M | ﹤0.01% | 1791 |
|
|
2021
Q3 | $74.1M | Buy |
1,658,630
+288,008
| +21% | +$12.9M | ﹤0.01% | 1508 |
|
|
2021
Q2 | $51.9M | Buy |
1,370,622
+507,389
| +59% | +$19.2M | ﹤0.01% | 1817 |
|
|
2021
Q1 | $31.9M | Buy |
863,233
+698,102
| +423% | +$25.8M | ﹤0.01% | 2058 |
|
|
2020
Q4 | $5.47M | Buy |
+165,131
| New | +$5.47M | ﹤0.01% | 2917 |
|